REPLIGEN CORP - COMMON STOCK (RGEN)

CUSIP: 759916109

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,095,854
Total 13F shares
53,769,139
Share change
+420,776
Total reported value
$9,050,236,781
Put/Call ratio
55%
Price per share
$168.36
Number of holders
442
Value change
+$70,900,818
Number of buys
202
Number of sells
200

Quarterly Holders Quick Answers

What is CUSIP 759916109?
CUSIP 759916109 identifies RGEN - REPLIGEN CORP - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q1 2023

As of 31 Mar 2023, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 442 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,769,139 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, BROWN CAPITAL MANAGEMENT LLC, Invesco Ltd., and Artisan Partners Limited Partnership. This page lists 442 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.